Search Results - "Stanca, Oana"
-
1
Classic Hodgkin lymphoma-nodular sclerosis – case report
Published in Revista medicală Română (30-06-2023)“…Hodgkin's lymphoma is the third most common cancer in young people between 15 and 34 years of age, with a lower incidence in other age groups and slightly…”
Get full text
Journal Article -
2
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group
Published in American journal of hematology (01-06-2020)“…In recent years, considerable progress has been made in frontline therapy for elderly/physically unfit patients with CLL. The combination of obinutuzumab and…”
Get full text
Journal Article -
3
Immunohistochemistry in the therapeutic decision for Hodgkin’s lymphoma
Published in Practica medicală (2006) (31-03-2024)“…Hodgkin's lymphoma is a highly curable malignant hemopathy in both adults and children with therapy adapted to risk factors, including both chemotherapy and…”
Get full text
Journal Article -
4
Classic Hodgkin Lymphoma – mixed cellularity – case report and review of literature
Published in Practica medicală (2006) (31-03-2023)“…Hodgkin's lymphoma, formerly known as Hodgkin's disease, is a type of cancer of the lymphatic system, an important part of the site where immune processes take…”
Get full text
Journal Article -
5
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Published in Leukemia (01-09-2020)“…Chronic lymphocytic leukemia (CLL) is a disease of the elderly, characterized by immunodeficiency. Hence, patients with CLL might be considered more…”
Get full text
Journal Article -
6
-
7
A Review of FLT3 Kinase Inhibitors in AML
Published in Journal of clinical medicine (01-10-2023)“…Acute myeloid leukemia (AML) is a highly aggressive illness distinguished by the accumulation of abnormal hematopoietic precursors in both the bone marrow and…”
Get full text
Journal Article -
8
The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL
Published in American journal of hematology (01-12-2023)“…In this retrospective international multicenter study, we describe the clinical characteristics and outcomes of patients with chronic lymphocytic leukemia…”
Get full text
Journal Article -
9
-
10
JAK2 R1063H Variant Enhances V617F Constitutive Signaling and Favors Development of Essential Thrombocythemia with Increased Hemoglobin and Neutrophils
Published in Blood (29-11-2018)“…The clinical consequences of the highly prevalent JAK2 V617F mutation in Ph-negative myeloproliferative neoplasms (MPNs) are well studied. However, the impact…”
Get full text
Journal Article -
11
Increased Dkk‐1 plasma levels may discriminate disease subtypes in myeloproliferative neoplasms
Published in Journal of cellular and molecular medicine (01-08-2018)“…Alterations in the bone marrow niche induced by abnormal production of cytokines and other soluble factors have been associated with disease progression in…”
Get full text
Journal Article -
12
Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms
Published in Blood (20-12-2018)Get full text
Journal Article -
13
Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies
Published in Genes (30-05-2021)“…Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range of genetic defects. Cytogenetics, molecular and genomic technologies…”
Get full text
Journal Article -
14
Perioperative Patient Blood Management Programme. Multidisciplinary recommendations from the Patient Blood Management Initiative Group
Published in Romanian journal of anaesthesia and intensive care (01-10-2017)“…Patients with untreated anaemia or iron deficiency who undergo surgical procedures have an increased risk for mortality and morbidity. Patient Blood Management…”
Get full text
Journal Article -
15
The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis
Published in Revista română de medicină de laborator (01-09-2013)“…Myelodysplastic syndromes (MDS) are a group of heterogeneous clonal stem cell disorders characterized by ineffective hematopoiesis with dysplastic changes in…”
Get full text
Journal Article -
16
-
17
Front-Line Treatment with Obinutuzumab ± Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice: Results of a Multinational, Multicenter Study By Eric and Icllsg
Published in Blood (13-11-2019)“…Chronic lymphocytic leukemia (CLL) occurs in older individuals with a median age at diagnosis of 72 years. In recent years, there has been considerable…”
Get full text
Journal Article -
18
Elevated Labile Plasma Iron (LPI) Levels in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Are Associated with Decreased Quality of Life and Reduced Survival
Published in BLOOD (29-11-2018)“…Background: Patients with lower-risk MDS (LR-MDS) are prone to iron toxicity due to long-term iron accumulation either caused by RBC transfusions or…”
Get full text
Journal Article Conference Proceeding -
19
The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis
Published in Revista română de medicină de laborator (01-09-2013)“…Sindroamele mielodisplazice (SMD) reprezintă un grup heterogen de hemopatii clonale ale celulei stem caracterizate prin hematopoieză ineficientă cu afectarea…”
Get full text
Journal Article -
20
The Impact of 2-(18) Fluoro-2-Deoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in Treatment Strategy of Hodgkin Lymphoma-Current Hematologic Concepts
Published in Mædica (01-06-2015)“…Positron emission tomography/computed tomography (PET/CT) is useful in staging of Hodgkin lymphoma (HL), for early response - adapted therapy and choosing an…”
Get full text
Journal Article